CAR-T Cancer Treatment Draws Patients to China as Costs Rise in U.S.

(NaturalNews) Patients from the U.S., New Zealand and other high-income countries are traveling to Shanghai for chimeric antigen receptor T-cell (CAR-T) therapy, a …